Testing Status of AZT transplacental carcinogenesis study M990048
CASRN: 30516-87-1
Formula: C10-H13-N5-O4
Synonyms/Common Names
- 3'-Azido-3'-deoxythymidine
- AZT Transplacental Carcinogenesis Study (AIDS Initiative)
Long-Term Carcinogenicity
- 19 months (In Utero)
(C99022)
Completed
- TR-522 (NIH Number: 06-4458)
(Peer Review Approval 12/09/2004A )
Toxicology and Carcinogenesis Studies of Transplacental AZT (CASRN 30516-87-1) in Swiss (CD-1®) Mice (in utero Studies) - Mice: Swiss CD-1
- Carcinogenesis Results
- Male Mice Clear Evidence
- Female Mice No Evidence
- Dose: AZT: 50, 100, 200, OR 300 MG/KG/DAY; 25, 25, 36, OR 46 PER GROUP.
- TR-522 (NIH Number: 06-4458)
(Peer Review Approval 12/09/2004A )
Special Studies
- Toxicokinetic Study (Intravenous; Dosed-Water)
(S0874)
Completed
- Female Mice: SWISS CD-1